BC
WGS icon

Bridgefront Capital’s GeneDx Holdings WGS Stock Holding History

Bridgefront Capital’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$348K Buy
+5,412
New +$494K 0.09% 352

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bridgefront Capital's WGS Position: Q1 2026 in Review

Bridgefront Capital opened a new position in GeneDx Holdings (WGS) in Q1 2026: 5,412 shares worth $348K. The stake represents 0.09% of the portfolio and ranks #352 among its holdings.

240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Bridgefront Capital held 5,412 shares of GeneDx Holdings worth $348K as of Q1 2026.
  • GeneDx Holdings was a new Bridgefront Capital position in Q1 2026.
  • GeneDx Holdings made up 0.09% of Bridgefront Capital's portfolio in Q1 2026, its #352 holding.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.